Offer - Urjas Oil for just ₹ 1 X
Reclimet Tablet (15) is a prescription drug, available for use as Tablet. Diabetes are some of its major therapeutic uses. The alternative uses of Reclimet Tablet (15) have also been explained below.
The optimal dosage of Reclimet Tablet (15) is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Reclimet Tablet (15) include Nausea or vomiting, Bradycardia, Constipation. Some other side effects of Reclimet Tablet (15) have been listed ahead. These side effects of Reclimet Tablet (15) are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Reclimet Tablet (15) is Moderate for pregnant women and Safe for women who are breastfeeding. It is important to know if Reclimet Tablet (15) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Reclimet Tablet (15) related warnings section.
Other contraindications of Reclimet Tablet (15) have been discussed in the sections ahead.
Drug reaction of Reclimet Tablet (15) with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Reclimet Tablet (15) is safe while driving, and is is addictive in nature.
Reclimet Tablet (15) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Reclimet Tablet (15) safe for pregnant women?
Reclimet can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Reclimet right away. Take your doctor's advice before taking it again.
Is the use of Reclimet Tablet (15) safe during breastfeeding?
Reclimet is completely safe for breastfeeding women.
What is the effect of Reclimet Tablet (15) on the Kidneys?
Reclimet can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Reclimet Tablet (15) on the Liver?
Reclimet may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Reclimet Tablet (15) on the Heart?
There may be severe side effects of Reclimet on your heart. Do not take it unless a doctor says so.
Reclimet Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Reclimet Tablet (15) unless your doctor advises you to do so -
Is this Reclimet Tablet (15) habit forming or addictive?
Reclimet Tablet (15) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Reclimet Tablet (15) as it does not make you drowsy.
Is it safe?
Yes, but consume Reclimet Tablet (15) only on doctor's advice.
Is it able to treat mental disorders?
Reclimet Tablet (15) is unable to treat or cure mental disorders.
Interaction between Food and Reclimet Tablet (15)
Taking Reclimet Tablet (15) with food does not harm your health.
Interaction between Alcohol and Reclimet Tablet (15)
Consuming Reclimet Tablet (15) with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1314-1315
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826